Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bba8e8bc4bcb014b856015f7ed47c08fc> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bba8e8bc4bcb014b856015f7ed47c08fc NCIT_P378 "NCI" @default.
- Bba8e8bc4bcb014b856015f7ed47c08fc type Axiom @default.
- Bba8e8bc4bcb014b856015f7ed47c08fc annotatedProperty IAO_0000115 @default.
- Bba8e8bc4bcb014b856015f7ed47c08fc annotatedSource NCIT_C1887 @default.
- Bba8e8bc4bcb014b856015f7ed47c08fc annotatedTarget "A recombinant, humanized monoclonal antibody directed against CD22, a cell surface glycoprotein present on mature B-cells and on many types of malignant B-cells. After binding to CD22, epratuzumab's predominant antitumor activity appears to be mediated through antibody-dependent cellular cytotoxicity (ADCC)." @default.